AVAH

Aveanna raises its 2026 outlook and long-term growth targets as reimbursement gains and preferred payers support expansion.

Aveanna Healthcare Holdings Inc. (AVAH) Q2 2026 Earnings Call Transcript

Aveanna Healthcare Holdings delivered strong Q2 2026 results, beating earnings and revenue estimates and significantly raising full-year EBITDA and revenue guidance. AVAH's valuation remains attractive versus peers, with the lowest forward P/E multiples and leading EBITDA margin, despite a 60% stock price gain since March. Private Duty Services drive 83% of revenues, but gross margins declined across all segments; rapid revenue growth offset margin pressure, yet this trend warrants monitoring.

Aveanna Healthcare NASDAQ: AVAH reported higher second-quarter revenue and adjusted EBITDA, supported by growth across its three operating divisions, improved reimbursement rates, increased volumes and operational efficiencies. The company also raised its full-year outlook and updated its long-term organic growth targets for its Private Duty Services and Home Health and Hospice businesses.

Although the revenue and EPS for Aveanna (AVAH) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Aveanna Healthcare (AVAH) came out with quarterly earnings of $0.22 per share, beating the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.18 per share a year ago.

Second Quarter Revenue was $670.5 million, a 13.7% increase over the prior year period Second Quarter Net income was $40.3 million compared to $27.0 million for the prior year period Adjusted EBITDA for Q2 2026 was $95.4 million, an 8.0% increase over the prior year period Increased Full Year 2026 Revenue guidance to greater than $2.68 billion, updated from between $2.63 and $2.65 billion Increased Full Year 2026 Adjusted EBITDA guidance to greater than $365 million, updated from between $338 and $342 million ATLANTA, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced financial results for the three and six-month periods ended July 4, 2026. Jeff Shaner, Chief Executive Officer, commented, “Our second quarter results demonstrate the momentum across Aveanna and our ability to consistently deliver sustained year-over-year growth.

AVAH's Q2 revenues are expected to rise 9.8%, but lower PDS margins and higher costs may weigh on earnings.

Investors need to pay close attention to AVAH stock based on the movements in the options market lately.

Besides Wall Street's top-and-bottom-line estimates for Aveanna (AVAH), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2026.